Advertisement
Screener

RHYTHM PHARMACEUTICALS, INC. (RYTM) Graph

RYTM Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $71.25M; Revenue including tax (m); Cost of revenue $8.93M; Research and development $43.43M.
  • 2026-03-31: Revenue $60.11M; Revenue including tax (m); Cost of revenue $7.16M; Research and development $41.73M.
  • 2025-12-31: Revenue $57.25M*; Revenue including tax (m); Cost of revenue $4.80M*; Research and development $42.03M*.
  • 2025-09-30: Revenue $51.30M; Revenue including tax (m); Cost of revenue $5.50M; Research and development $46.03M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

RYTM revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.License$0.00Product$71.26MRevenue$71.26MCost of revenue$8.93MOperating income-$48.55MOther income, net$1.02MResearch & development$43.43MSelling, general& administrative$67.45MPre-tax income-$48.85MNet income-$49.30M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

RYTM revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Single ReportableSegment$71.26MRevenue$71.26MCost of revenue$8.93MOperating income-$48.55MOther income, net$1.02MResearch & development$43.43MSelling, general& administrative$67.45MPre-tax income-$48.85MNet income-$49.30M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$71.25M(m)$8.93M$43.43M$67.45M(m)$444.00K-$49.30M
2026-03-31$60.11M(m)$7.16M$41.73M$63.59M(m)$545.00K-$55.64M
2025-12-31$57.25M*(m)$4.80M*$42.03M*$57.48M*(m)-$31.00K*$148.84M*
2025-09-30$51.30M(m)$5.50M$46.03M$52.42M(m)$111.00K-$52.90M
2025-06-30$48.50M(m)$5.54M$42.31M$45.95M(m)$337.00K-$46.63M
2025-03-31$32.70M(m)$3.65M$36.97M$39.09M(m)$80.00K-$49.50M
2024-09-30$33.25M(m)$3.83M$37.93M$35.38M(m)-$344.00K-$43.64M
2024-06-30$29.08M$29.08M$2.95M$30.19M$36.41M(m)$479.00K-$32.26M
2024-03-31$25.97M$25.97M$2.81M$128.66M$34.38M(m)$300.00K-$141.37M
2023-12-31(m)$24.23M*(m)(m)(m)(m)(m)(m)
2023-09-30$22.50M$22.50M$2.41M$33.57M$30.48M(m)$368.00K-$44.16M
2023-06-30(m)$19.22M$2.24M$33.54M$30.05M(m)(m)-$46.70M
2023-03-31(m)$11.47M$1.42M$37.95M$24.63M(m)$0.00-$52.18M
2022-09-30(m)$4.28M$497.00K$21.12M$21.94M(m)(m)-$40.86M
2022-06-30(m)$9.07M$378.00K$31.46M$22.33M(m)(m)-$45.00M
2022-03-31(m)$1.50M$230.00K$32.51M$21.45M(m)$0.00-$52.76M
2021-09-30(m)$1.03M$222.00K$27.54M$17.51M(m)-$8.99M-$35.11M
2021-06-30(m)$274.00K$137.00K$25.10M$15.46M(m)-$5.02M-$35.39M
2021-03-31(m)$35.00K$4.00K$19.91M$14.52M(m)$22.01M$43.75M
2020-12-31(m)(m)(m)(m)(m)$35.07M*(m)(m)
2020-09-30(m)(m)(m)$23.00M$11.29M$34.28M(m)-$33.82M
2020-06-30(m)(m)(m)$23.00M$8.92M$31.92M(m)-$31.12M
2020-03-31(m)(m)(m)$22.50M$12.80M$35.30M(m)-$34.16M
2019-12-31(m)(m)(m)(m)(m)$34.22M(m)-$32.96M
2019-09-30(m)(m)(m)$26.57M$10.54M$37.11M(m)-$36.00M
2019-06-30(m)(m)(m)$35.31M$8.84M$44.15M(m)-$42.80M
2019-03-31(m)(m)(m)$22.76M$7.76M$30.52M(m)-$28.97M
2018-12-31(m)(m)(m)(m)(m)$27.15M(m)-$25.51M
2018-09-30(m)(m)(m)$10.71M$8.54M$19.24M(m)-$17.69M
2018-06-30(m)(m)(m)$8.58M$6.44M$15.02M(m)-$14.41M
2018-03-31(m)(m)(m)$12.29M$4.71M$17.00M(m)-$16.46M
2017-12-31(m)(m)(m)(m)(m)$10.98M(m)(m)
2017-09-30(m)(m)(m)$5.97M$2.31M$8.29M(m)(m)
2017-06-30(m)(m)(m)$5.40M$1.36M$6.75M(m)(m)
2017-03-31(m)(m)(m)$4.87M$1.52M$6.39M(m)(m)
2016-12-31(m)(m)(m)(m)(m)$8.38M(m)(m)
2016-09-30(m)(m)(m)$5.42M(m)$6.40M(m)(m)
2016-06-30(m)(m)(m)(m)(m)$5.74M(m)(m)
2016-03-31(m)(m)(m)(m)(m)$5.39M(m)(m)

Revenue and expense 6 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$131.37M(m)$16.09M$85.15M$131.04M(m)$989.00K-$104.94M
2025-06-30$81.21M(m)$9.19M$79.28M$85.03M(m)$417.00K-$96.13M
2024-06-30$55.05M$55.05M$5.75M$158.86M$70.80M(m)$779.00K-$173.63M
2023-06-30(m)$30.69M$3.66M$71.49M$54.67M(m)$0.00-$98.88M
2022-06-30(m)$10.56M$608.00K$63.97M$43.78M(m)(m)-$97.77M
2021-06-30(m)$309.00K$141.00K$45.02M$29.98M(m)$16.98M$8.36M
2020-06-30(m)(m)(m)$45.50M$21.72M$67.22M(m)-$65.28M
2019-06-30(m)(m)(m)$58.07M$16.60M$74.67M(m)-$71.77M
2018-06-30(m)(m)(m)$20.87M$11.15M$32.02M(m)(m)
2017-06-30(m)(m)(m)$10.27M$2.87M$13.14M(m)(m)

Revenue and expense 9 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$132.50M(m)$14.69M$125.31M$137.46M(m)$528.00K-$149.03M
2024-09-30$88.30M(m)$9.58M$196.79M$106.17M(m)$436.00K-$217.31M
2023-09-30$53.19M$53.19M$6.07M$105.06M$85.16M(m)$368.00K-$143.04M
2022-09-30(m)$14.85M$1.10M$85.08M$65.72M(m)(m)-$138.63M
2021-09-30(m)$1.34M$363.00K$72.55M$47.49M(m)$7.99M-$26.75M
2020-09-30(m)(m)(m)$68.50M$33.01M$101.50M(m)-$99.10M
2019-09-30(m)(m)(m)$84.64M$27.14M$111.78M(m)-$107.77M
2018-09-30(m)(m)(m)$31.57M$19.69M$51.27M(m)(m)
2017-09-30(m)(m)(m)$16.24M$5.19M$21.43M(m)(m)
2016-09-30(m)(m)(m)$13.96M(m)$17.53M(m)(m)

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$189.76M(m)$19.49M$167.34M$194.94M(m)$497.00K-$196.54K
2024-12-31$130.13M(m)$13.37M$237.96M$144.30M(m)$346.00K-$260.60K
2023-12-31$77.43M$77.43M$9.30M$134.95M$117.53M(m)$564.00K-$184.68K
2022-12-31$23.64M$23.64M$2.13M$108.63M$92.03M(m)(m)-$181.12K
2021-12-31$3.15M$3.15M$599.00K$104.13M$68.49M(m)(m)-$69.61K
2020-12-31(m)$0.00(m)$90.45M$46.13M$136.57M(m)-$134.00M
2019-12-31(m)$0.00(m)$109.45M$36.55M$146.00M(m)-$140.73M
2018-12-31$0.00$0.00(m)$50.34M$28.08M$78.42M(m)-$74.06M
2017-12-31$0.00$0.00(m)$22.89M$9.52M$32.41M(m)-$33.71M
2016-12-31$0.00(m)(m)$19.59M$6.31M$25.91M(m)(m)
2015-12-31(m)(m)(m)$7.15M$3.42M$10.57M(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alkermes plc. (ALKS)$6.844B132.74
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60